113-53-1

113-53-1结构式
113-53-1结构式
  • 常用中文名:度硫平
  • 常用英文名:(E)-Dosulepin
  • CAS号:113-53-1
  • 分子式:C19H21NS
  • 分子量:295.44
  • 相关类别: 信号通路 G 蛋白偶联受体/G 蛋白 5-HT受体
  • 发布时间:2018-05-26 08:00:00
  • 更新时间:2024-01-02 20:22:32
  • Dothiepin是一种具有镇静/抗焦虑活性的抗抑郁药。多蒂平是一种抑制剂,它更喜欢去甲肾上腺素的摄取,而不是血清素的摄取。多蒂平通过抑制神经元摄取促进去甲肾上腺素能神经传递。多蒂平也是组胺H1受体的拮抗剂,没有心脏毒性。Dothiepin在心因性面部疼痛、特发性纤维肌痛综合征或类风湿性关节炎中表现出显著的镇痛活性[1]。

化源商城直购

中文名 度琉平
英文名 dothiepin
中文别名 度硫平
英文别名 1-Propanamine, 3-dibenzo[b,e]thiepin-11(6H)-ylidene-N,N-dimethyl-, (3E)-
11-(3-Dimethylamino-propyliden)-6,11-dihydro-dibenzo<b.e>thiepin
Methiaden
Dothiepin
Dolsulepine
Dosulepin
Prothiadene
Dosulepine
11-(3-Dimethylaminopropylidene)-6,11-dihydrodibenzo(b,e)thiepin
(3E)-3-(Dibenzo[b,e]thiepin-11(6H)-ylidene)-N,N-dimethyl-1-propanamine
досулепин
iz914
Dothep
trans-dothiepin
Prothiaden
11(16H)-(3-[dimethylamino]propylidene)dibenz[b,e]thiopine
EINECS 204-031-2
描述 Dothiepin是一种具有镇静/抗焦虑活性的抗抑郁药。多蒂平是一种抑制剂,它更喜欢去甲肾上腺素的摄取,而不是血清素的摄取。多蒂平通过抑制神经元摄取促进去甲肾上腺素能神经传递。多蒂平也是组胺H1受体的拮抗剂,没有心脏毒性。Dothiepin在心因性面部疼痛、特发性纤维肌痛综合征或类风湿性关节炎中表现出显著的镇痛活性[1]。
相关类别
靶点

Histamine H1-receptor, Noradrenaline uptake (α1-and α2-adrenoceptors and serotonin 5HT1 and 5HT2-receptors)[1]

参考文献

[1]. Lancaster SG, et al. Dothiepin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs. 1989 Jul;38(1):123-47.  

密度 1.1±0.1 g/cm3
沸点 430.9±44.0 °C at 760 mmHg
熔点 55-57ºC
分子式 C19H21NS
分子量 295.44
闪点 214.4±28.4 °C
精确质量 295.139465
PSA 28.54000
LogP 4.34
外观性状 淡黄色低熔点固体
蒸汽压 0.0±1.0 mmHg at 25°C
折射率 1.661
分子结构

1、 摩尔折射率:95.07

2、 摩尔体积(cm3/mol):257.2

3、 等张比容(90.2K):687.4

4、 表面张力(dyne/cm):50.9

5、 极化率(10-24cm3):37.68

CHEMICAL IDENTIFICATION

RTECS NUMBER :
UI1555000
CHEMICAL NAME :
Propylamine, N,N-dimethyl-3-(dibenzo(b,e)thiepin-delta-sup(11(6H), gamma))-
CAS REGISTRY NUMBER :
113-53-1
LAST UPDATED :
199712
DATA ITEMS CITED :
9
MOLECULAR FORMULA :
C19-H21-N-S
MOLECULAR WEIGHT :
295.47
WISWESSER LINE NOTATION :
T C676 BY IS JHJ BU3N1&1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - infant
DOSE/DURATION :
100 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - coma Cardiac - arrhythmias (including changes in conduction)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
4500 ug/kg
TOXIC EFFECTS :
Behavioral - changes in motor activity (specific assay)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human
DOSE/DURATION :
3214 ug/kg/12D-I
TOXIC EFFECTS :
Behavioral - changes in psychophysiological tests
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human
DOSE/DURATION :
2143 ug/kg/8D-I
TOXIC EFFECTS :
Behavioral - sleep Behavioral - hallucinations, distorted perceptions Behavioral - changes in psychophysiological tests
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
31 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
150 mg/kg
SEX/DURATION :
male 6 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea)
TYPE OF TEST :
Cytogenetic analysis

MUTATION DATA

TEST SYSTEM :
Rodent - mouse
DOSE/DURATION :
150 mg/kg
REFERENCE :
ACNSAX Activitas Nervosa Superior. (Avicenum, Malostranske nam. 28, Prague 1, Czechoslovakia) V.1- 1959- Volume(issue)/page/year: 15,114,1973

危险品运输编码 UN 3249
包装等级 III
危险类别 6.1(b)

~%

113-53-1结构式

113-53-1

文献:WO2007/136743 A2, ; Page/Page column 20-21 ;
上游产品  1

下游产品  1